Abstract
To investigate the safety and efficacy of laparoscopic partial cystectomy in the treatment of bladder diverticular carcinoma. A retrospective analysis was performed on the clinical data of 12 patients diagnosed with bladder diverticular carcinoma who were treated at Quanzhou First Hospital Affiliated to Fujian Medical University between January 2016 and May 2023. All patients underwent laparoscopic partial cystectomy. The study assessed surgical parameters (e.g., operation time, intraoperative blood loss), pathological findings (tumor grade, stage, surgical margin status), postoperative complications, adjuvant treatment regimens, and long-term follow-up outcomes (tumor recurrence, survival status). All 12 operations were completed successfully without major intraoperative complications. Postoperative pathology confirmed bladder urothelial carcinoma in all cases, with negative surgical margins in all patients. Postoperatively, all patients received regular intravesical instillation chemotherapy. Additionally, 5 patients underwent systemic intravenous chemotherapy, and 1 patient received intra-arterial chemotherapy as adjuvant treatment to reduce the risk of tumor recurrence. The median follow-up duration was 16-49 months. During follow-up, 11 patients remained free of tumor recurrence, while 1 patient developed recurrent bladder cancer at 15 months postoperatively (subsequently managed with transurethral resection of bladder tumor and adjuvant radiotherapy, achieving long-term survival). Laparoscopic partial cystectomy is a safe and effective therapeutic option for bladder diverticular carcinoma, characterized by low postoperative complication rates and favorable tumor control. Larger-sample, multi-center studies with longer follow-up are needed to further validate its long-term prognostic benefits.